Folate receptor α (FRα) is overexpressed on numerous tumorous cell types such as ovarian
or endometrial cancer cells. Moreover, FRα is absent from most healthy tissues as it is …

The folate receptor (FR) is expressed in many tumor types, among those ovarian and lung
cancer. Due to the high FR affinity of folic acid, it has been used for targeting of FR-positive …

The folate receptor-α (FR-α) is overexpressed in many epithelial cancers, including ovary,
uterus, kidneys, breast, lung, colon and prostate carcinomas, but shows limited expression …

The folate receptor (FR) is overexpressed on a variety of tumor types, whereas its
distribution in normal tissues and organs is highly limited. Exploration of the utility of the FR …

The folate receptor (FR) is highly expressed on most epithelial cancer cells, while normal
cells show only restricted expression of FR. As a result, the FR is an ideal target for receptor …

Overexpression of folate receptors (FRs) on different tumor types (eg, ovarian, lung) make
FRs attractive in vivo targets for directed diagnostic/therapeutic agents. Currently, no …

Frequent overexpression of the folate receptor (FR) on a variety of tumor types and on
activated macrophages makes this re-ceptor an interesting target for both imaging and …

The folate receptor (FR) is upregulated in various cancer types (FR-α isoform) and in
activated macrophages (FR-β isoform) which are involved in inflammatory and autoimmune …

The folate receptor (FR) is already known as a proven target in diagnostics and therapy of
cancer. Furthermore, the FR is involved in inflammatory and autoimmune diseases. The …

Purpose The folate receptor (FR) is a valuable tumour marker, since it is frequently
overexpressed on various cancer types. The purpose of the present study was to pre …